Alle verbonden artikelen

Liquid biopsy-based clinical research in early breast cancer: The EORTC 90091-10093 Treat CTC trial.

Auteurs : Ignatiadis M, Rack B, Rothé F, Riethdorf S, Decraene C, Bonnefoi H, Dittrich C, Messina C, Beauvois M, Trapp E, Goulioti T, Tryfonidis K, Pantel K, Repollet M, Janni W, Piccart-Gebhart M, Sotiriou C, Litiere S, Pierga JY
Jaar : 2016
Journal : Eur J Cancer
Volume : 63
Pagina's : 97-104

Biopsies of the Internal Mammary Sentinel Lymph Nodes in Breast Cancer

Auteurs : Roman M, Karler C, Nogaret JM, Bourgeois P, Philippson C
Jaar : 2016
Journal : J. Surgery
Volume : 4
Pagina's : 1

Real-time in-vivo microscopic imaging of the cervix using confocal laser endomicroscopy: preliminary observations and feasibility study.

Auteurs : Degueldre M, Vandromme J, de Wind A, Feoli F
Jaar : 2016
Journal : Eur. J. Cancer Prev.
Volume : 25(4)
Pagina's : 335-43

The genomic landscape of breast cancer and its interaction with host immunity.

Auteurs : Luen S, Virassamy B, Savas P, Salgado R, Loi S
Jaar : 2016
Journal : Breast
Volume : 29
Pagina's : 241-50

Use of intraoperative radiation therapy in the conservative treatment of invasive male breast cancer.

Auteurs : Fromont A, Nogaret JM, De Neubourg F, Philippson C
Jaar : 2016
Journal : Rev Med Brux
Volume : 37(1)
Pagina's : 40-5

BHS guidelines for the treatment of large granular lymphocyte and cronic prolymphocytic leukaemias

Auteurs : Delrieu V, Wu KL, Schroyens W, Bonnet C, Bron D, Janssens A
Jaar : 2016
Journal : Belgian J Hematology
Volume : 7
Pagina's : 103-11

The protein phosphatase 2A regulatory subunit PR70 is a gonosomal melanoma tumor suppressor gene.

Auteurs : Van Kempen LC, Redpath M, Elchebly M, Klein KO, Papadakis AI, Wilmott JS, Scolyer RA, Edqvist PH, Pontén F, Schadendorf D, van Rijk AF, Michiels S, Dumay A, Helbling-Leclerc A, Dessen P, Wouters J, Stass M, Greenwood CM, Ghanem G, van den Oord J, Feunteun J, Spatz A
Jaar : 2016
Journal : Sci Transl Med
Volume : 8
Pagina's : 369ra177

Correlative Analysis of Genetic Alterations and Everolimus Benefit in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Results From BOLERO-2.

Auteurs : Hortobagyi GN, Chen D, Piccart-Gebhart M, Rugo HS, Burris HA 3rd, Pritchard KI, Campone M, Noguchi S, Perez AT, Deleu I, Shtivelband M, Masuda N, Dakhil S, Anderson I, Robinson DM, He W, Garg A, McDonald ER 3rd, Bitter H, Huang A, Taran T, Bachelot T, Lebrun F, Lebwohl D, Baselga J
Jaar : 2016
Journal : J Clin Oncol
Volume : 34(5)
Pagina's : 419-26

Squalene epoxidase is a bona fide oncogene by amplification with clinical relevance in breast cancer.

Auteurs : Brown DN, Caffa I, Cirmena G, Piras D, Garuti A, Gallo M, Alberti S, Nencioni A, Ballestrero A, Zoppoli G
Jaar : 2016
Journal : Sci Rep
Volume : 6
Pagina's : 19435

Results of a comparative analysis of magnetic resonance imaging-targeted versus three-dimensional transrectal ultrasound prostate biopsies: Size does matter.

Auteurs : Peltier A, Aoun F, Albisinni S, Marcelis Q, Ledinh D, Paesmans M, Lemort M, Van Velthoven R
Jaar : 2016
Journal : Scand J Urol
Volume : 50(3)
Pagina's : 144-8

Increased mortality in hematological malignancy patients with acute respiratory failure from undetermined etiology: a Groupe de Recherche en Réanimation Respiratoire en Onco-Hématologique (Grrr-OH) study.

Auteurs : Contejean A, Lemiale V, Resche-Rigon M, Mokart D, Pène F, Kouatchet A, Mayaux J, Vincent F, Nyunga M, Bruneel F, Rabbat A, Perez P, Meert AP, Benoit D, Hamidfar R, Darmon M, Jourdain M, Renault A, Schlemmer B, Azoulay E
Jaar : 2016
Journal : Ann Intensive Care
Volume : 6
Pagina's : 102

Corrigendum: Frequent somatic transfer of mitochondrial DNA into the nuclear genome of human cancer cells.

Auteurs : Ju YS, Tubio JM, Mifsud W, Fu B, Davies HR, Ramakrishna M, Li Y, Yates L, Gundem G, Tarpey PS, Behjati S, Papaemmanuil E, Martin S, Fullam A, Gerstung M, Nangalia J, Green AR, Caldas C, Borg Å, Tutt A, Lee MT, Vant Veer LJ, Tan BK, Aparicio S, Span PN, Martens JW, Knappskog S, Vincent-Salomon A, Børresen-Dale AL, Eyfjörd JE, Myklebost O, Flanagan AM, Foster C, Neal DE, Cooper C, Eeles R, Bova GS, Lakhani SR, Desmedt C, Thomas G, Richardson AL, Purdie CA, Thompson AM, McDermott U, Yang F, Nik-Zainal S, Campbell PJ, Stratton MR
Jaar : 2016
Journal : Genome Res
Volume : 26
Pagina's : 717.2

Drugs prescribed for patients hospitalized in a geriatric oncology unit: Potentially inappropriate medications and impact of a clinical pharmacist.

Auteurs : Deliens C, Deliens G, Filleul O, Pepersack T, Awada A, Piccart-Gebhart M, Praet JP, Dal Lago L
Jaar : 2016
Journal : J Geriatr Oncol
Volume : 7(6)
Pagina's : 463-70

Adding checkpoint inhibitors to tyrosine kinase inhibitors targeting EGFR/ALK in non-small cell lung cancer: a new therapeutic strategy.

Auteurs : Tabchi S, Kourie HR, Kattan J
Jaar : 2016
Journal : Invest New Drugs
Volume : 34(6)
Pagina's : 794-6

Effects of Estrogen Receptor and Human Epidermal Growth Factor Receptor-2 Levels on the Efficacy of Trastuzumab: A Secondary Analysis of the HERA Trial.

Auteurs : Loi S, Dafni U, Karlis D, Polydoropoulou V, Young BM, Willis S, Long B, de Azambuja E, Sotiriou C, Viale G, Rüschoff J, Piccart-Gebhart M, Dowsett M, Michiels S, Leyland-Jones B
Jaar : 2016
Journal : JAMA Oncol
Volume : 2(8)
Pagina's : 1040-7

Which factors predict overall survival in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate post-docetaxel?

Auteurs : Van Praet C, Rottey S, Van Hende F, Pelgrims G, Demey W, Van Aelst F, Wynendaele W, Gil T, Schatteman P, Filleul B, Schallier D, Machiels JP, Schrijvers D, Everaert E, DHondt L, Werbrouck P, Vermeij J, Mebis J, Clausse M, Van Erps J, Verheezen J, Van Haverbeke J, Goeminne JC, Lumen N
Jaar : 2016
Journal : European urology supplements
Volume : 15(3)
Pagina's : -

A European Organisation for Research and Treatment of Cancer randomized, double-blind, placebo-controlled, multicentre phase II trial of anastrozole in combination with gefitinib or placebo in hormone receptor-positive advanced breast cancer (NCT0006

Auteurs : Tryfonidis K, Basaran G, Bogaerts J, Debled M, Dirix L, Thery JC, Tjan-Heijnen VC, Van den Weyngaert D, Cufer T, Piccart-Gebhart M, Cameron D
Jaar : 2016
Journal : Eur J Cancer
Volume : 53
Pagina's : 144-54

Long-acting octreotide as secondary prevention of chemotherapy-induced diarrhea: proof of concept.

Auteurs : VAN DEN Heuvel B, Peeters M, Hendlisz A, Van den Eynde M, Machiels G, Dero I, Geboes K, De Man M, Hendrickx K, Delaunoit T, Monsaert E, Vanderstraten E, Van Laethem JL, Lybaert W, Holbrechts S, Rolfo C
Jaar : 2016
Journal : Minerva Chir

Levator Ani Necrosis: An Exceptional Complication Occurring after High Intensity Focused Ultrasound" of the Prostate."

Auteurs : Badawy D, El Rassy E, Aoun F, Van Velthoven R
Jaar : 2016
Journal : Case Rep Urol
Volume : 2016
Pagina's : 3920976

Efficacy of weekly paclitaxel treatment as a single agent chemotherapy following first-line cisplatin treatment in urothelial bladder cancer.

Auteurs : Sideris S, Aoun F, Zanaty M, Martinez NC, Latifyan S, Awada A, Gil T
Jaar : 2016
Journal : Mol Clin Oncol
Volume : 4
Pagina's : 1063-1067